Gastrointestinal Imaging

Which Imaging Study Is Best for Epigastric Pain with Suspected Gastric Cancer?

·
Which Imaging Study Is Best for Epigastric Pain with Suspected Gastric Cancer?

A 68-year-old male presents to your clinic with three months of persistent, gnawing epigastric pain, a 15-pound unintentional weight loss, and early satiety. His history is notable for chronic gastritis treated intermittently over the years. Given the alarm features, your clinical suspicion for gastric malignancy is high, and you need to decide on the most appropriate initial imaging study to evaluate the stomach. This clinical decision point—choosing the right first-line test—is critical for timely diagnosis and avoiding unnecessary procedures. According to the American College of Radiology (ACR) Appropriateness Criteria, for a patient with epigastric pain and clinical suspicion for gastric cancer, a Fluoroscopy upper GI series is rated Usually Appropriate as an initial imaging examination.

Who Fits This Clinical Scenario for Suspected Gastric Cancer?

This guidance applies specifically to patients presenting with epigastric pain accompanied by one or more “alarm features” that raise the clinical index of suspicion for a gastric malignancy. The key is the combination of symptoms, not just isolated epigastric discomfort.

Inclusion criteria for this workflow:

  • Persistent or new-onset epigastric pain in a patient typically over 50-60 years of age.
  • Presence of alarm features such as:
  • Unintentional weight loss
  • Dysphagia (difficulty swallowing) or odynophagia (painful swallowing)
  • Early satiety (feeling full after eating a small amount)
  • Unexplained iron deficiency anemia
  • Persistent vomiting
  • A palpable epigastric mass on physical examination.
  • A significant family history of gastric cancer or personal history of conditions like chronic atrophic gastritis or intestinal metaplasia.

This workflow does NOT apply to:

  • Patients with typical reflux symptoms: Individuals with classic heartburn, regurgitation, and relief with antacids, but without the alarm features listed above, fit a different clinical scenario for suspected GERD or peptic ulcer disease.
  • Patients with positional or intermittent symptoms suggesting a hernia: If the pain is clearly associated with bending over, lying down, or large meals, and suggests a hiatal hernia, a different imaging pathway may be more appropriate.
  • Patients with acute, severe, or peritoneal signs: A sudden onset of severe pain, fever, and abdominal rigidity suggests an acute process like perforation, which requires an emergent and different diagnostic algorithm, often starting with an upright chest radiograph or CT scan.

What Diagnoses Are You Working Up in This Scenario?

When ordering imaging for suspected gastric cancer, you are evaluating a differential that extends beyond the most common type of malignancy. The goal of the initial study is to identify anatomic abnormalities that warrant definitive endoscopic evaluation.

Gastric Adenocarcinoma
This is the most common gastric malignancy and the primary diagnosis of concern. It can appear on imaging as a discrete mass (polypoid), an ulcerative lesion with irregular margins, or as diffuse thickening of the gastric wall. Imaging aims to detect these primary signs within the stomach lining.

Gastric Lymphoma
While less common than adenocarcinoma, primary gastric lymphoma is the most frequent extranodal site for non-Hodgkin lymphoma. It often presents as marked, uniform thickening of the gastric wall and folds, which can be difficult to distinguish from adenocarcinoma or severe gastritis on imaging alone.

Gastrointestinal Stromal Tumor (GIST)
GISTs are mesenchymal tumors that typically arise from the deeper layers of the stomach wall (muscularis propria). On imaging, they often appear as smooth, well-defined submucosal masses that may or may not have central ulceration. They tend to grow outward (exophytic) from the stomach.

Complicated or Malignant Peptic Ulcer
A benign peptic ulcer typically has smooth, regular folds radiating to the ulcer crater. In contrast, an ulcerated malignancy often has irregular, nodular, or clubbed surrounding folds that do not extend to the crater’s edge. While endoscopy is definitive, imaging can provide initial clues to differentiate a benign process from a malignant one.

Linitis Plastica (Scirrhous Gastric Cancer)
This is a rare but aggressive form of diffusely infiltrating adenocarcinoma. Instead of forming a discrete mass, the cancer cells spread throughout the stomach wall, causing it to become thick, rigid, and non-distensible. This “leather bottle” appearance is a classic finding on a fluoroscopic upper GI series.

Why Is a Fluoroscopy Upper GI Series Recommended for This Presentation?

For the initial evaluation of a patient with suspected gastric cancer, the ACR identifies both Fluoroscopy upper GI series and CT of the abdomen and pelvis with IV contrast as Usually Appropriate. The choice between them often depends on institutional preference and the specific clinical question. However, the upper GI series offers unique advantages for this specific indication.

A fluoroscopic upper GI series, particularly a double-contrast (or biphasic) study, excels at evaluating the mucosal surface of the stomach. The barium coats the lining, while air distends the lumen, allowing for detailed visualization of subtle ulcers, polyps, and abnormal fold patterns. This dynamic, real-time assessment is highly effective for detecting mucosal abnormalities and assessing gastric distensibility and peristalsis—key for identifying the rigid stomach of linitis plastica.

Comparison with Other Modalities:

  • CT Abdomen and Pelvis with IV Contrast: Also rated Usually Appropriate, CT is superior for evaluating the thickness of the gastric wall and, crucially, for staging. It can readily detect lymph node involvement, direct invasion of adjacent organs, and distant metastases (e.g., to the liver or peritoneum). While it can identify large gastric masses, it is less sensitive than a high-quality upper GI series for subtle mucosal lesions.
  • MRI Abdomen: Rated Usually not appropriate for this initial workup. MRI has limited utility in evaluating the gastric mucosa due to motion artifacts from breathing and peristalsis. Its role is typically reserved for problem-solving, such as characterizing a liver lesion found on another study, not for the primary detection of a gastric tumor.
  • FDG-PET/CT: Rated Usually not appropriate as a first-line diagnostic tool. PET/CT is a powerful modality for staging confirmed cancer and assessing treatment response. However, using it for initial diagnosis is inefficient, exposes the patient to significant radiation (☢☢☢☢ 10-30 mSv), and can have false positives from inflammatory conditions like gastritis.

The radiation dose for a Fluoroscopy upper GI series is moderate (adult relative radiation level ☢☢☢, 1-10 mSv), similar to that of a standard contrast-enhanced CT of the abdomen and pelvis. The decision between UGI and CT often hinges on whether the primary goal is initial detection (favoring UGI’s mucosal detail) or simultaneous detection and staging (favoring CT’s comprehensive view).

What’s Next After the Initial Imaging? Downstream Workflow

The result of the initial imaging study directly informs the next step in the patient’s workup. Regardless of the imaging findings, a high clinical suspicion for malignancy almost always culminates in endoscopic evaluation.

If the Study Is Positive (Suspicious Finding)
A finding on UGI or CT suggestive of malignancy—such as an ulcerated mass, nodular fold thickening, or a discrete filling defect—mandates a direct referral to a gastroenterologist for an esophagogastroduodenoscopy (EGD). EGD allows for direct visualization of the lesion and, most importantly, for obtaining tissue biopsies to establish a definitive histopathologic diagnosis. This is a non-negotiable step before any treatment planning can begin.

If the Study Is Negative (No Abnormality Detected)
A normal UGI or CT scan in a patient with persistent alarm features (e.g., weight loss, early satiety) does not rule out gastric cancer. Both imaging modalities can miss small, flat, or diffusely infiltrating lesions. Therefore, if your clinical suspicion remains high despite a negative imaging report, the next step is still to proceed with an EGD for direct mucosal evaluation and biopsy. Do not let a negative scan provide false reassurance in the face of compelling clinical signs.

If the Study Is Indeterminate
An equivocal finding, such as mild, nonspecific gastric wall thickening, also warrants progression to EGD. Endoscopy is the gold standard for resolving such ambiguities, as it can differentiate between severe gastritis, lymphoma, and infiltrating carcinoma through visual inspection and tissue sampling. In some cases, a complementary imaging study (e.g., a CT if a UGI was performed first) might be considered, but EGD is typically the most direct and highest-yield next step.

Pitfalls to Avoid (and When to Get Help)

Navigating the workup for suspected gastric cancer requires vigilance to avoid common diagnostic traps.

  • Pitfall 1: Inadequate Gastric Distention. A collapsed stomach on either CT or a UGI series can create the false appearance of wall thickening. Ensure the radiology department uses a protocol with adequate oral contrast (for CT) or effervescent crystals (for UGI) to distend the stomach properly.
  • Pitfall 2: Stopping the Workup After a Negative Scan. This is the most critical pitfall. Alarm features like unintentional weight loss or iron deficiency anemia are strong indicators for endoscopy, even if initial imaging is unremarkable.
  • Pitfall 3: Assuming an Ulcer is Benign. While imaging can suggest features of a benign ulcer, malignancy can only be excluded with multiple biopsies obtained during endoscopy. Never manage a gastric ulcer based on imaging appearance alone without histologic confirmation.

Escalate immediately to a gastroenterology or surgical specialist if the patient develops signs of a complication, such as hematemesis or melena (bleeding), intractable vomiting (obstruction), or sudden, severe abdominal pain with peritoneal signs (perforation). These are medical emergencies.

Related ACR Topics and Tools

For a comprehensive overview of imaging for all types of epigastric pain and to explore adjacent clinical scenarios, please consult the resources below. For breadth across all scenarios in Epigastric Pain, see our parent guide: Epigastric Pain: ACR Appropriateness Decoded.

Frequently Asked Questions

Why not just go straight to endoscopy (EGD) for every patient with epigastric pain?

For patients with undifferentiated epigastric pain without alarm features (like weight loss, anemia, or dysphagia), direct-to-endoscopy is not the most efficient approach. Many have benign conditions like gastritis or GERD that can be managed empirically. Imaging or other non-invasive tests are often used first. However, in this specific scenario—where clinical suspicion for cancer is high due to alarm features—EGD is the definitive diagnostic test, and imaging serves as a complementary initial step.

If CT is also ‘Usually Appropriate’, when should I choose it over a Fluoroscopy Upper GI series?

Choose CT over a UGI series when your primary concern extends beyond just detecting a mucosal lesion to staging the disease. If the patient has a palpable mass or signs suggestive of metastatic disease (e.g., jaundice, ascites), CT provides a comprehensive evaluation of the gastric wall, regional lymph nodes, liver, and peritoneum in a single study. A UGI series is often preferred when the primary goal is a highly detailed look at the gastric mucosa for a subtle lesion.

What is a ‘double-contrast’ or ‘biphasic’ upper GI series?

A double-contrast upper GI series is a fluoroscopic technique that uses both a high-density barium suspension to coat the mucosal lining and gas (from effervescent crystals the patient swallows) to distend the stomach. This combination provides a detailed, relief map of the gastric surface, making it superior to single-contrast (barium only) studies for detecting fine mucosal abnormalities like small ulcers, polyps, or the subtle rigidity of linitis plastica.

Does a normal H. pylori test lower the suspicion for gastric cancer?

Not necessarily, especially in the presence of alarm symptoms. While chronic Helicobacter pylori infection is a major risk factor for developing gastric adenocarcinoma, its absence does not rule out cancer. Many gastric cancers arise in patients without a current H. pylori infection. The clinical presentation, particularly alarm features, should always guide the diagnostic workup, regardless of H. pylori status.

Can I use an abdominal ultrasound to evaluate for gastric cancer?

Abdominal ultrasound is generally not a reliable tool for the primary diagnosis of gastric cancer. Bowel gas within the stomach typically obscures the view of the gastric wall and mucosa. While a very large, advanced tumor or liver metastases might be incidentally seen, ultrasound is not sensitive or specific for this indication and is considered inappropriate for the initial workup.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 29, 2026